GC Aesthetics, a provider of silicone breast implants in Latin America and EMEA, filed on Wednesday with the SEC to raise up to $75 million in an initial public offering.
The Dublin, Ireland-based company, which was founded in 1979 and booked $55 million in sales for the 12 months ended March 31, 2015, plans to list on the NASDAQ. It has not selected a ticker symbol. GC Aesthetics initially filed confidentially on 5/15/2015. BofA Merrill Lynch, Deutsche Bank and Cowen & Company are the joint bookrunners on the deal. No pricing terms were disclosed.
